Bhutan

Reimbursed Care Access

Bhutan’s narcotics and psychotropic controls are implemented through domestic law that adopts the UN schedules; most classical psychedelics (psilocybin, MDMA, DMT, mescaline, etc.) are classified with no authorized medical use except within tightly regulated medical/scientific channels. Ketamine is used in medical settings (anesthesia) under controlled-drug rules, but specialized psychiatric products such as esketamine (Spravato) are not registered or reimbursed in Bhutan and have no routine psychiatric reimbursement pathway.